Bifogade filer
PDF
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Continued strong growth
"Increased commercial activity and new development initiatives create growth and we see many opportunities to
develop the business further."
Fredrik Dalborg, President and CEO
AddLife's interim report for Q2 2023 is now available online at the company website. The interim report can be downloaded in pdf version. Visit reports-en.add.life/interim-report-q2-2023
1 APRIL - 30 JUNE 2023 (3 MONTHS)- Net sales increased by 14% to SEK 2,365 m (2,079). The COVID-19 related sales decreased to 0 m (36) and the organic growth excluding, COVID-19 related sales and exchange rate changes, was 8%.
- EBITA increased by 3% to SEK 247 m (240), corresponding to an EBITA-margin of 10.4% (11.6).
- Profit after tax amounted to SEK 33 m (76).
- Earnings per share amounted to SEK 0.27 (0.63).
- Cash flow from operating activities amounted to SEK 82 m (206). Capital tied up increased as a result of strong growth.
- Net sales increased by 4% to SEK 4,822 m (4,658), whereof the acquired growth amounted to 1%. The COVID-19 related sales decreased to 0 m (546) and the organic growth excluding, COVID-19 related sales, was 10%.
- EBITA decreased by 9% to SEK 613 m (675), corresponding to an EBITA-margin of 12.7% (14.5). EBITA includes a reversed contingent consideration amounting to 83 m, adjusted for this the EBITA-margin amounts to 11.0%.
- Profit after tax amounted to SEK 207 m (301).
- Earnings per share amounted to SEK 1.70 (2.47). Earnings per share for the last 12 months amounted to SEK 3.19 (5.07).
- Cash flow from operating activities amounted to SEK 187 m (538).
- The equity ratio was 38% (38).
- Return on working capital (P/WC) amounted to 53% (61).
Stockholm, July 14, 2023 AddLife AB (publ)
For more information, contact;
Fredrik Dalborg, CEO, fredrik.dalborg@add.life,+46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life,+46 70 546 72 22
www.add.life
Video conference
Investors, analysts and the media are invited to a video conference at which CEO Fredrik Dalborg and CFO Christina Rubenhag will present the interim report. The presentation will be given in English and take about 20 minutes after which there will be an opportunity to ask questions. The meeting will be recorded and made available online.
The video conference will be at 11 a.m. CET on July 14, 2023
If you wish to participate via video conference, please follow this link>> (https://teams.microsoft.com/l/meetup-join/19%3ameeting_NTNjYmIwYTktN2ZjNy00OGJlLWE4ZGYtNzA3OTlkMjkxZDNh%40thread.v2/0?context=%7b%22Tid%22%3a%2220971130-9feb-4ac0-96f1-e7fbd0d840e4%22%2c%22Oid%22%3a%220c82b078-ea3a-456f-8f96-17f869ce86a7%22%7d)
The presentation is also available on AddLife YouTube >> (https://www.youtube.com/channel/UC_YiKbKavYICoTU37Y0C8pg)
AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,200 employees in some 85 operating subsidiaries. The Group currently has net sales of approximately SEK 9 billion. AddLife shares are listed on Nasdaq Stockholm.
This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at July 14, 2023 at 07:45 a.m. CET.